DE69728769D1 - Polymerzusammensetzung zur oralen administration von peptiden und proteinen - Google Patents

Polymerzusammensetzung zur oralen administration von peptiden und proteinen

Info

Publication number
DE69728769D1
DE69728769D1 DE69728769T DE69728769T DE69728769D1 DE 69728769 D1 DE69728769 D1 DE 69728769D1 DE 69728769 T DE69728769 T DE 69728769T DE 69728769 T DE69728769 T DE 69728769T DE 69728769 D1 DE69728769 D1 DE 69728769D1
Authority
DE
Germany
Prior art keywords
oral administration
peptides
proteins
polymer composition
therapeutic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69728769T
Other languages
English (en)
Other versions
DE69728769T2 (de
Inventor
Nikolai A Plate
Lev I Valuev
Tatyana A Valueva
Ludmila K Staroseltseva
Alexander S Ametov
Vladimir A Knyazhev
M Henis
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Orex Pharmaceutical Development Corp
Original Assignee
Orex Pharmaceutical Development Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US08/691,617 external-priority patent/US6004583A/en
Application filed by Orex Pharmaceutical Development Corp filed Critical Orex Pharmaceutical Development Corp
Application granted granted Critical
Publication of DE69728769D1 publication Critical patent/DE69728769D1/de
Publication of DE69728769T2 publication Critical patent/DE69728769T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/42—Proteins; Polypeptides; Degradation products thereof; Derivatives thereof, e.g. albumin, gelatin or zein
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/46—Ingredients of undetermined constitution or reaction products thereof, e.g. skin, bone, milk, cotton fibre, eggshell, oxgall or plant extracts

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Inorganic Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
DE69728769T 1996-08-02 1997-07-30 Polymerzusammensetzung zur oralen administration von peptiden und proteinen Expired - Fee Related DE69728769T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US08/691,617 US6004583A (en) 1995-03-22 1996-08-02 Protein-containing polymer composition for oral administration
US691617 1996-08-02
PCT/US1997/013352 WO1998005362A2 (en) 1996-08-02 1997-07-30 Protein-containing polymer composition for oral administration

Publications (2)

Publication Number Publication Date
DE69728769D1 true DE69728769D1 (de) 2004-05-27
DE69728769T2 DE69728769T2 (de) 2005-03-31

Family

ID=24777264

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69728769T Expired - Fee Related DE69728769T2 (de) 1996-08-02 1997-07-30 Polymerzusammensetzung zur oralen administration von peptiden und proteinen

Country Status (8)

Country Link
EP (1) EP0918543B1 (de)
AT (1) ATE264693T1 (de)
AU (1) AU3819297A (de)
BR (1) BR9710908A (de)
DE (1) DE69728769T2 (de)
DK (1) DK0918543T3 (de)
ES (1) ES2219773T3 (de)
WO (1) WO1998005362A2 (de)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6645485B2 (en) * 2000-05-10 2003-11-11 Allan R. Dunn Method of treating inflammation in the joints of a body
JP5175553B2 (ja) * 2005-02-01 2013-04-03 エミスフェアー・テクノロジーズ・インク 胃内滞留および制御放出型送達系
WO2013188497A2 (en) * 2012-06-15 2013-12-19 Agentase, Llc, A Subsidiary Of Flir Systems, Inc. A smart, self-decontaminating polymer and method for inhibiting the growth of a bacteria and fungus

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0098110B1 (de) * 1982-06-24 1989-10-18 NIHON CHEMICAL RESEARCH KABUSHIKI KAISHA also known as JAPAN CHEMICAL RESEARCH CO., LTD Zusammensetzung mit längerer Wirkung
DE3604868A1 (de) * 1986-02-15 1987-08-20 Behringwerke Ag Insulinderivate, verfahren zu ihrer herstellung und ihre verwendung
US5359030A (en) * 1993-05-10 1994-10-25 Protein Delivery, Inc. Conjugation-stabilized polypeptide compositions, therapeutic delivery and diagnostic formulations comprising same, and method of making and using the same
EP0705298B1 (de) * 1993-12-01 2002-03-27 Bioartificial Gel Technologies Inc. Hydrogel auf basis von albumin
RU2066551C1 (ru) * 1994-03-23 1996-09-20 Институт нефтехимического синтеза РАН Способ получения инсулинсодержащих полимерных гидрогелей
RU2076733C1 (ru) * 1994-03-23 1997-04-10 Институт нефтехимического синтеза им.А.В.Топчеева РАН Способ получения производных инсулина

Also Published As

Publication number Publication date
DK0918543T3 (da) 2004-07-26
BR9710908A (pt) 2000-10-24
ES2219773T3 (es) 2004-12-01
DE69728769T2 (de) 2005-03-31
WO1998005362A3 (en) 1998-05-07
EP0918543A2 (de) 1999-06-02
AU3819297A (en) 1998-02-25
EP0918543B1 (de) 2004-04-21
ATE264693T1 (de) 2004-05-15
WO1998005362A2 (en) 1998-02-12

Similar Documents

Publication Publication Date Title
WO1997014806A3 (en) Delivery of biologically active polypeptides
NO995313D0 (no) Mikroartikler nyttige som ultrasoniske kontrastmidler og til levering av legemidler i blodbanen
ATE263579T1 (de) Abgabe von polyethylene glycol-molekül- konjugaten aus abbaubarem hydrogel
ES2126536B1 (es) "preparado farmaceutico para administracion intranasal y procedimientopara su produccion".
ATE417604T1 (de) Matrix mit verzögerter freisetzung für hochdosierte unlösliche arzneistoffe
EA199700233A1 (ru) Дозирующий ингалятор для салметерола
DE69937294D1 (de) Von cyclophilin b abstammende tumorantigen-peptide
EA199700232A1 (ru) Дозирующий ингалятор для пропионата флутиказона
ATE327254T1 (de) Interferon-beta fusionsproteine und deren verwendungen
DK0436005T3 (da) Mærkede polypeptidderivater
IS2866B (is) Magavarin ómeprasólörkorn, aðferð til að fá slík og lyfjaefnablöndur
ATE338771T1 (de) Antagonisten des intestinotrophen glp-2 peptides
FR2766193B1 (fr) Polypeptide chimerique comprenant le fragment b de la toxine shiga et des peptides d'interet therapeutique
ATE247981T1 (de) Proteinenthaltende pharmazeutische zubereitung
SE9604593D0 (sv) Antimicrobially active polypeptides
DE69728769D1 (de) Polymerzusammensetzung zur oralen administration von peptiden und proteinen
FR2797185B1 (fr) Composition pharmaceutique flottante comprenant une phase active et une phase non active
BR9810285A (pt) Solução, composição farmacêutica, e, cápsula de gelatina.
AU6804394A (en) Oral pharmaceutical compositions comprising a protein or peptide, an antibody and polymeric beads
DE69704269T2 (de) Dendritische, lysinhaltige Polypeptide zur gezielten Arzneimittelabreichung
DE69738600D1 (de) Neuroaktive peptide
ATE447027T1 (de) Bakterielle pheromone und deren verwendungen
DE60236330D1 (de) Biologisch aktive Peptide
ATE93527T1 (de) Peptide und deren benutzung.
MX9604539A (es) Aminoacidos modificados para la distribucion de farmaco.

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee